Literature DB >> 23780890

Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology.

Charles Ferté1, Andrew D Trister, Erich Huang, Brian M Bot, Justin Guinney, Frederic Commo, Solveig Sieberts, Fabrice André, Benjamin Besse, Jean-Charles Soria, Stephen H Friend.   

Abstract

The progressive introduction of high-throughput molecular techniques in the clinic allows for the extensive and systematic exploration of multiple biologic layers of tumors. Molecular profiles and classifiers generated from these assays represent the foundation of what the National Academy describes as the future of "precision medicine". However, the analysis of such complex data requires the implementation of sophisticated bioinformatic and statistical procedures. It is critical that oncology practitioners be aware of the advantages and limitations of the methods used to generate classifiers to usher them into the clinic. This article uses publicly available expression data from patients with non-small cell lung cancer to first illustrate the challenges of experimental design and preprocessing of data before clinical application and highlights the challenges of high-dimensional statistical analysis. It provides a roadmap for the translation of such classifiers to clinical practice and makes key recommendations for good practice. ©2013 AACR.

Entities:  

Mesh:

Year:  2013        PMID: 23780890      PMCID: PMC3745509          DOI: 10.1158/1078-0432.CCR-12-3937

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  68 in total

1.  Outcome signature genes in breast cancer: is there a unique set?

Authors:  Liat Ein-Dor; Itai Kela; Gad Getz; David Givol; Eytan Domany
Journal:  Bioinformatics       Date:  2004-08-12       Impact factor: 6.937

Review 2.  Biomarkers and surrogate end points--the challenge of statistical validation.

Authors:  Marc Buyse; Daniel J Sargent; Axel Grothey; Alastair Matheson; Aimery de Gramont
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

3.  An integrative genomics approach to infer causal associations between gene expression and disease.

Authors:  Eric E Schadt; John Lamb; Xia Yang; Jun Zhu; Steve Edwards; Debraj Guhathakurta; Solveig K Sieberts; Stephanie Monks; Marc Reitman; Chunsheng Zhang; Pek Yee Lum; Amy Leonardson; Rolf Thieringer; Joseph M Metzger; Liming Yang; John Castle; Haoyuan Zhu; Shera F Kash; Thomas A Drake; Alan Sachs; Aldons J Lusis
Journal:  Nat Genet       Date:  2005-06-19       Impact factor: 38.330

4.  Sample size planning for developing classifiers using high-dimensional DNA microarray data.

Authors:  Kevin K Dobbin; Richard M Simon
Journal:  Biostatistics       Date:  2006-04-13       Impact factor: 5.899

5.  Caveats and pitfalls of ROC analysis in clinical microarray research (and how to avoid them).

Authors:  Daniel Berrar; Peter Flach
Journal:  Brief Bioinform       Date:  2011-03-21       Impact factor: 11.622

Review 6.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

Review 7.  Clinical trial designs for predictive marker validation in cancer treatment trials.

Authors:  Daniel J Sargent; Barbara A Conley; Carmen Allegra; Laurence Collette
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

Review 8.  Tackling the widespread and critical impact of batch effects in high-throughput data.

Authors:  Jeffrey T Leek; Robert B Scharpf; Héctor Corrada Bravo; David Simcha; Benjamin Langmead; W Evan Johnson; Donald Geman; Keith Baggerly; Rafael A Irizarry
Journal:  Nat Rev Genet       Date:  2010-09-14       Impact factor: 53.242

9.  Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

Authors:  Chang-Qi Zhu; Keyue Ding; Dan Strumpf; Barbara A Weir; Matthew Meyerson; Nathan Pennell; Roman K Thomas; Katsuhiko Naoki; Christine Ladd-Acosta; Ni Liu; Melania Pintilie; Sandy Der; Lesley Seymour; Igor Jurisica; Frances A Shepherd; Ming-Sound Tsao
Journal:  J Clin Oncol       Date:  2010-09-07       Impact factor: 44.544

10.  Supervised normalization of microarrays.

Authors:  Brigham H Mecham; Peter S Nelson; John D Storey
Journal:  Bioinformatics       Date:  2010-03-31       Impact factor: 6.937

View more
  17 in total

1.  Metabolomics technology and bioinformatics for precision medicine.

Authors:  Rajeev K Azad; Vladimir Shulaev
Journal:  Brief Bioinform       Date:  2019-11-27       Impact factor: 11.622

Review 2.  Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects.

Authors:  Christina Backes; Eckart Meese; Andreas Keller
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

3.  mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in mice.

Authors:  Brandi N Snyder-Talkington; Chunlin Dong; Linda M Sargent; Dale W Porter; Lauren M Staska; Ann F Hubbs; Rebecca Raese; Walter McKinney; Bean T Chen; Lori Battelli; David T Lowry; Steven H Reynolds; Vincent Castranova; Yong Qian; Nancy L Guo
Journal:  J Appl Toxicol       Date:  2015-04-29       Impact factor: 3.446

4.  A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression.

Authors:  Ashley A Smith; Yen-Tsung Huang; Melissa Eliot; E Andres Houseman; Carmen J Marsit; John K Wiencke; Karl T Kelsey
Journal:  Epigenetics       Date:  2014-03-26       Impact factor: 4.528

5.  Blocking and randomization to improve molecular biomarker discovery.

Authors:  Li-Xuan Qin; Qin Zhou; Faina Bogomolniy; Liliana Villafania; Narciso Olvera; Magali Cavatore; Jaya M Satagopan; Colin B Begg; Douglas A Levine
Journal:  Clin Cancer Res       Date:  2014-05-01       Impact factor: 12.531

6.  mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in mice.

Authors:  Julian Dymacek; Brandi N Snyder-Talkington; Dale W Porter; Robert R Mercer; Michael G Wolfarth; Vincent Castranova; Yong Qian; Nancy L Guo
Journal:  Toxicol Sci       Date:  2014-12-18       Impact factor: 4.849

7.  Making External Validation Valid for Molecular Classifier Development.

Authors:  Yilin Wu; Huei-Chung Huang; Li-Xuan Qin
Journal:  JCO Precis Oncol       Date:  2021-08-05

8.  Differential distribution improves gene selection stability and has competitive classification performance for patient survival.

Authors:  Dario Strbenac; Graham J Mann; Jean Y H Yang; John T Ormerod
Journal:  Nucleic Acids Res       Date:  2016-05-17       Impact factor: 16.971

Review 9.  Molecular portraits: the evolution of the concept of transcriptome-based cancer signatures.

Authors:  Angelika Modelska; Alessandro Quattrone; Angela Re
Journal:  Brief Bioinform       Date:  2015-03-31       Impact factor: 11.622

10.  An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.

Authors:  Lu Ao; Xuekun Song; Xiangyu Li; Mengsha Tong; You Guo; Jing Li; Hongdong Li; Hao Cai; Mengyao Li; Qingzhou Guan; Haidan Yan; Zheng Guo
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.